30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bob Hombach

Track

Insider profile

Currently holds positions in Baxalta Inc, Biomarin Pharmaceutical Inc, Carmax Inc and Aptinyx Inc

Positions

Position Company Period
Chief Financial Officer, Chief Operating Officer, Executive Vice President Baxalta Inc None -
Independent Director Biomarin Pharmaceutical Inc Sept. 28, 2017 -
Independent Director Carmax Inc April 1, 2018 -
Independent Director Aptinyx Inc May 1, 2018 -
Chief Financial Officer, Corporate Vice President Baxter International Inc March 23, 2011 - Jan. 1, 2015
Bob Hombach's trades of Aptinyx Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-15 2021-11-12
US Aptinyx Inc (APTX)
B Purchase
99,154 +40.4%
333.96
US$2,817,602 		99,154 +40.4% 333.96 US$2,817,602
2021-11-15 2021-11-11
US Aptinyx Inc (APTX)
B Purchase
54,365 +5.0%
68.69
US$3,057,442 		54,365 +5.0% 68.69 US$3,057,442
2020-01-14 2020-01-10
US Aptinyx Inc (APTX)
B Purchase
34,877 -15.1%
25.77
US$805,144 		34,877 -15.1% 25.77 US$805,144
2019-01-28 2019-01-25
US Aptinyx Inc (APTX)
B Purchase
11,655 +31.1%
5.54
US$64,569 		11,655 +31.1% 5.54 US$64,569
2019-01-28 2019-01-24
US Aptinyx Inc (APTX)
B Purchase
13,345 +55.4%
5.52
US$73,664 		13,345 +55.4% 5.52 US$73,664